These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36509043)

  • 1. Stereotactic Radiotherapy in Early-Stage Breast Cancer in Neoadjuvant and Exclusive Settings: A Systematic Review.
    Piras A; Sanfratello A; Boldrini L; D'Aviero A; Pernice G; Sortino G; Valerio MR; Gennari R; D'Angelo I; Marazzi F; Angileri T; Daidone A
    Oncol Res Treat; 2023; 46(3):116-123. PubMed ID: 36509043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in breast cancer treatment: a systematic review of preoperative stereotactic body radiotherapy (SBRT) for breast cancer.
    Bilski M; Konat-Bąska K; Zerella MA; Corradini S; Hetnał M; Leonardi MC; Gruba M; Grzywacz A; Hatala P; Jereczek-Fossa BA; Fijuth J; Kuncman Ł
    Radiat Oncol; 2024 Aug; 19(1):103. PubMed ID: 39095859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereotactic image-guided neoadjuvant ablative single-dose radiation, then lumpectomy, for early breast cancer: the SIGNAL prospective single-arm trial of single-dose radiation therapy.
    Guidolin K; Yaremko B; Lynn K; Gaede S; Kornecki A; Muscedere G; BenNachum I; Shmuilovich O; Mouawad M; Yu E; Sexton T; Gelman N; Moiseenko V; Brackstone M; Lock M
    Curr Oncol; 2019 Jun; 26(3):e334-e340. PubMed ID: 31285677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypofractionated radiotherapy in pancreatic cancer: Lessons from the past in the era of stereotactic body radiation therapy.
    De Bari B; Porta L; Mazzola R; Alongi F; Wagner AD; Schäfer M; Bourhis J; Ozsahin M
    Crit Rev Oncol Hematol; 2016 Jul; 103():49-61. PubMed ID: 27233119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereotactic Body Radiotherapy for High-Risk Prostate Cancer: A Systematic Review.
    Foerster R; Zwahlen DR; Buchali A; Tang H; Schroeder C; Windisch P; Vu E; Akbaba S; Bostel T; Sprave T; Zamboglou C; Zilli T; Stelmes JJ; Telkhade T; Murthy V
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33673077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase 1 clinical trial of stereotactic body radiation therapy concomitant with neoadjuvant chemotherapy for breast cancer.
    Bondiau PY; Courdi A; Bahadoran P; Chamorey E; Queille-Roussel C; Lallement M; Birtwisle-Peyrottes I; Chapellier C; Pacquelet-Cheli S; Ferrero JM
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1193-9. PubMed ID: 23332384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Neoadjuvant Therapy for Operable Locally Invasive Non-Small-Cell Lung Cancer. Phase I Study of Neoadjuvant Stereotactic Body Radiotherapy. LINNEARRE I (NCT02433574).
    Nguyen NA; Isfahanian N; Pond G; Hanna W; Cutz JC; Wright J; Swaminath A; Shargall Y; Chow T; Wierzbicki M; Okawara G; Quan K; Finley C; Juergens R; Tsakiridis T
    Clin Lung Cancer; 2017 Jul; 18(4):436-440.e1. PubMed ID: 28215851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicenter prospective phase II study of postoperative hypofractionated stereotactic body radiotherapy (SBRT) in the treatment of early-stage oropharyngeal and oral cavity cancers with high risk margins: the STEREO POSTOP GORTEC 2017-03 trial.
    Biau J; Thivat E; Millardet C; Saroul N; Pham-Dang N; Molnar I; Pereira B; Durando X; Bourhis J; Lapeyre M
    BMC Cancer; 2020 Aug; 20(1):730. PubMed ID: 32758188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant stereotactic body radiation therapy for nonmetastatic pancreatic adenocarcinoma.
    Jiang W; Haque W; Verma V; Butler EB; Teh BS
    Acta Oncol; 2019 Sep; 58(9):1259-1266. PubMed ID: 31237185
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparisons of different neoadjuvant chemotherapy regimens with or without stereotactic body radiation therapy for borderline resectable pancreatic cancer: study protocol of a prospective, randomized phase II trial (BRPCNCC-1).
    Gao S; Zhu X; Shi X; Cao K; Bian Y; Jiang H; Wang K; Guo S; Zhang H; Jin G
    Radiat Oncol; 2019 Mar; 14(1):52. PubMed ID: 30917842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reirradiation spine stereotactic body radiation therapy for spinal metastases: systematic review.
    Myrehaug S; Sahgal A; Hayashi M; Levivier M; Ma L; Martinez R; Paddick I; Régis J; Ryu S; Slotman B; De Salles A
    J Neurosurg Spine; 2017 Oct; 27(4):428-435. PubMed ID: 28708043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring All Avenues for Radiotherapy in Oligorecurrent Prostate Cancer Disease Limited to Lymph Nodes: A Systematic Review of the Role of Stereotactic Body Radiotherapy.
    Ponti E; Lancia A; Ost P; Trippa F; Triggiani L; Detti B; Ingrosso G
    Eur Urol Focus; 2017 Dec; 3(6):538-544. PubMed ID: 28801240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereotactic body radiation therapy in the re-irradiation situation--a review.
    Mantel F; Flentje M; Guckenberger M
    Radiat Oncol; 2013 Jan; 8():7. PubMed ID: 23289496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathologic response with neoadjuvant chemotherapy and stereotactic body radiotherapy for borderline resectable and locally-advanced pancreatic cancer.
    Rajagopalan MS; Heron DE; Wegner RE; Zeh HJ; Bahary N; Krasinskas AM; Lembersky B; Brand R; Moser AJ; Quinn AE; Burton SA
    Radiat Oncol; 2013 Oct; 8():254. PubMed ID: 24175982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deep learning radiomics of ultrasonography can predict response to neoadjuvant chemotherapy in breast cancer at an early stage of treatment: a prospective study.
    Gu J; Tong T; He C; Xu M; Yang X; Tian J; Jiang T; Wang K
    Eur Radiol; 2022 Mar; 32(3):2099-2109. PubMed ID: 34654965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility and preliminary clinical results of linac-based Stereotactic Body Radiotherapy for spinal metastases using a dedicated contouring and planning system.
    Giaj-Levra N; Niyazi M; Figlia V; Napoli G; Mazzola R; Nicosia L; Corradini S; Ruggieri R; Minniti G; Alongi F
    Radiat Oncol; 2019 Oct; 14(1):184. PubMed ID: 31655620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accelerated Hypofractionated Radiotherapy Versus Stereotactic Body Radiotherapy for the Treatment of Stage I Nonsmall Cell Lung Cancer-A Single Institution Experience With Long-Term Follow-Up.
    Karasawa K; Hayakawa S; Machitori Y; Shibata Y; Ogawa H; Ito K; Shimizuguchi T; Kawamoto T; Nihei K
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818806318. PubMed ID: 30317929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotactic body radiotherapy for de novo spinal metastases: systematic review.
    Husain ZA; Sahgal A; De Salles A; Funaro M; Glover J; Hayashi M; Hiraoka M; Levivier M; Ma L; Martínez-Alvarez R; Paddick JI; Régis J; Slotman BJ; Ryu S
    J Neurosurg Spine; 2017 Sep; 27(3):295-302. PubMed ID: 28598293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective observational study of the clinical and pathological impact of stereotactic body radiotherapy (SBRT) as a neoadjuvant strategy of chemoradiation in pancreatic cancer.
    Chen-Zhao X; Hernando O; López M; Sánchez E; Montero A; García-Aranda M; Ciérvide R; Valero J; Alonso R; Cárdenas-Rebollo JM; Vicente E; Quijano Y; Cubillo A; Álvarez R; Prados S; Plaza C; García J; Zucca D; Fernández-Letón P; Rubio C
    Clin Transl Oncol; 2020 Sep; 22(9):1499-1505. PubMed ID: 31974820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant durvalumab with or without stereotactic body radiotherapy in patients with early-stage non-small-cell lung cancer: a single-centre, randomised phase 2 trial.
    Altorki NK; McGraw TE; Borczuk AC; Saxena A; Port JL; Stiles BM; Lee BE; Sanfilippo NJ; Scheff RJ; Pua BB; Gruden JF; Christos PJ; Spinelli C; Gakuria J; Uppal M; Binder B; Elemento O; Ballman KV; Formenti SC
    Lancet Oncol; 2021 Jun; 22(6):824-835. PubMed ID: 34015311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.